Modification of therapy for complicated parapneumonic effusion or empyema complicating CAP in adults
For complicated parapneumonic effusion or empyema complicating CAP in adults, modify antibiotic therapy based on the results of microbiological investigations, noting that these infections are typically polymicrobial.
Once the patient has improved and, if drainage is feasible, the pleural space is adequately drained, switch to oral therapy. For guidance on when to switch to oral therapy, see Guidance for intravenous to oral switch. For oral continuation therapy for parapneumonic effusion or empyema complicating CAP in adults, use:
amoxicillin+clavulanate 875+125 mg orally, 12-hourly1. For dosage adjustment in adults with kidney impairment, see amoxicillin+clavulanate oral dosage adjustment. See advice on duration of therapy. amoxicillin + clavulanate amoxicillin+clavulanate amoxicillin+clavulanate
For adults with nonsevere (immediate or delayed) penicillin hypersensitivity, or severe immediate2 penicillin hypersensitivity who tolerated a ceftriaxone-based regimen3, use:
cefuroxime 500 mg orally, 12-hourly4. For dosage adjustment in adults with kidney impairment, see cefuroxime dosage adjustment. See advice on duration of therapy cefuroxime cefuroxime cefuroxime
PLUS
metronidazole 400 mg orally, 12-hourly. See advice on duration of therapy. metronidazole metronidazole metronidazole
For adults with severe immediate2 penicillin hypersensitivity in whom ceftriaxone was not used nor tolerated, or for patients with severe delayed5 penicillin hypersensitivity, use:
moxifloxacin 400 mg orally, daily. For dosage adjustment in adults with kidney impairment, see moxifloxacin dosage adjustment. See advice on duration of therapy. moxifloxacin moxifloxacin moxifloxacin